Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr177  -  BKR2 (human)

Site Information
GVRWAKLysLVIWGC   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 457134

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 ) , mutation of modification site ( 2 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Kinases, in vitro:
Src (human) ( 2 )

Downstream Regulation
Effects of modification on BKR2:
activity, induced ( 2 ) , phosphorylation ( 2 )



Possemato A (2009) CST Curation Set: 6906; Year: 2009; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Akt Substrate (RXRXXT-P) (81E12B5) Rabbit mAb Cat#: 10003
Curated Info


Hanke S, et al. (2006) Activated EGF receptor may balance ERK-inhibitory network signalling pathways. Cell Signal 18, 1031-40
16226010   Curated Info